MAPKAP-k2 Assay Kit, GFP Detection, 6 month assay evaluation
from
GE Healthcare, formerly Amersham Biosciences
Description
MAPKAP-k2
- Validated stable cell line: start screening immediately without having to spend months establishing a cell line in-house.
- Expression vector: offers the flexibility to work with transients and alternative host cell lines.
- Complete right to use: no additional license negotiations are required prior to using the assay.
- Direct observation of MAPKAP-k2 movement and location: permits pathway dissection in correct physiological context, identifies inhibitors of p38 MAPK signaling pathway .
- Cellular assay: identifies potentially toxic compounds without the need for additional reagents.
- Utilizes Aequorea victorea GFP: the established benchmark fluorescent protein technology.
MAPKAPK2
(MAPKAP kinase 2)